Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Papers: 5 Feb 2016 - 12 Feb 2016
Astrocytes in multiple sclerosis.
Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.
Papers: 31 Jul 2014 - 7 Aug 2014
Optic neuritis as a presenting symptom of Mycoplasma pneumoniae infection.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - YES.
A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
MS Research Roundup: January 15, 2014
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.

Pages